Contrast Agents III : Radiopharmaceuticals - From Diagnostics to Therapeutics

Uloženo v:
Podrobná bibliografie
Hlavní autor: Krause, Werner
Další autoři: Krause, Werner, 1949- (Editor)
Médium: Livre numérique
Jazyk:Anglais
Vydáno: Berlin, Heidelberg : Springer Berlin Heidelberg [20..].
Cham : Springer Nature
Vydání:1st ed. 2005.
Edice:Topics in Current Chemistry 252
Témata:
On-line přístup:Accès sur la plateforme de l'éditeur
Accès sur la plateforme Istex
Accès Université d'Orléans
Accès INSA CVL
Poznámka: Archives Springer e-books (Licence nationale)
Archives Springer e-books (Licence nationale)
Autres localisations: Voir dans le Sudoc
Variante du titre:with contributions by numerous experts
Edition sous un autre format:• Contrast agents, III, radiopharmaceuticals from diagnostics to therapeutics, volume editor : Werner Krause, Berlin, Springer, 2005, 1 vol. (VIII-222 p.), Topics in current chemistry, 3-540-22577-3
• Contrast Agents III, Texte imprimé, 9783642061455
• Contrast Agents III, Texte imprimé, 9783540802983
• Contrast agents, III, radiopharmaceuticals from diagnostics to therapeutics, volume editor : Werner Krause, Berlin, Springer, 2005, 1 vol. (VIII-222 p.), Topics in current chemistry, 3-540-22577-3
Obsah:
  • R. Alberto: New Organometallic Technetium Complexes for Radiopharmaceutical Imaging I. Santos, A. Paulo, J.D.G. Correia: Re and Tc Complexes Anchored by Phosphines and Scorpionates for Radiopharmaceutical Applications A. Boschi, A. Duatti, L.Uccelli: Development of Technetium-99m and Rhenium-188 Radiopharmaceuticals Containing a Terminal Metal-Nitrido Multiple Bond for Diagnosis and Therapy S. Liu: HYNIC Derivatives as Bifunctional Coupling Agents for 99mTc-Labeling of Small Biomolecules V. Sharma, D. Piwnica-Worms: Monitoring Multidrug Resistance P-glycoprotein (MDR1 Pgp) Drug Transport Activity with SPECT and PET Radiopharmaceuticals W.P. Li, L.A. Meyer, C.J. Anderson: Radiopharmceuticals for PET Imaging of Somatostatin Receptor Positive Tumors S. Liu, S.P. Robinson, D.S. Edwards: Radiolabeled Integrin avß3 Antagonists as Radiopharmaceuticals for Tumor Radiotherapy